Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-11

Clinical Trial Update: the Treatment of Human Bone Marrow Mesenchymal Stem Cells in Ocular Corneal Burn [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating human bone marrow mesenchymal stem cells for ocular corneal burns has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • bone marrow mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Chemical Burns | Phase 2 | Status: COMPLETED